References
- Sturm A, Maaser C, Mendall M, et al. European Crohn’s and Colitis Organisation topical review on IBD in the elderly. J Crohns Colitis. 2017;11:263–273.
- Arnott I, Rogler G, Halfvarson J. The management of inflammatory bowel disease in elderly: current evidence and future perspectives. Inflamm Intest Dis. 2018;2:189–199.
- Sigall-Boneh R, Levine A, Lomer M, et al. Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by D-ECCO Working Group [Dietitians of ECCO]. J Crohns Colitis. 2017;11:1407–1419.
- Bischoff SC, Escher J, Hébuterne X, et al. ESPEN Practical Guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020;39:632–653.
- Mijac DD, Jankovic GL, Jorga J, et al. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med. 2010;21:315–319.
- Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49–64.
- Sobotka L, Allison SP, Forbes A, et al. Basics in clinical nutrition. 4th ed. Prague: GALÉ; 2011.
- Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–569.
- Casanova MJ, Chaparro M, Molina B, et al. Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease. J Crohns Colitis. 2017;11:1430–1439.
- Ballinger A, El-Haj T, Perrett D, et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology. 2000;118:544–553.
- Eder P, Niezgodka A, Krela-Kazmierczak I, et al. Dietary support in elderly patients with inflammatory bowel disease. Nutrients. 2019;11:1421.
- Ananthakrishnan AN, McGinley EL, Binion DG, et al. A novel risk score to stratify severity of Crohn’s disease hospitalizations. Am J Gastroenterol. 2010;105:1799–1807.
- Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008;14:1105–1111.
- Wedrychowicz A, Zajac A, Tomasik P. Advances in nutritional therapy in inflammatory bowel diseases: review. World J Gastroenterol. 2016;22:1045–1066.
- Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182–189.
- Gheorghe C, Pascu O, Iacob R, et al. Nutritional risk screening and prevalence of malnutrition on admission to gastroenterology departments: a multicentric study. Chirurgia (Bucur). 2013;108:535–541.
- Dotson JL, Bricker JB, Kappelman MD, et al. Assessment of sex differences for treatment, procedures, complications, and associated conditions among adolescents hospitalized with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2619–2624.
- Gubatan J, Moss AC. Vitamin D in inflammatory bowel disease: more than just a supplement. Curr Opin Gastroenterol. 2018;34:217–225.
- Siva S, Rubin DT, Gulotta G, et al. Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease. InflammBowel Dis. 2017;23:152–157.
- Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13:517–526.
- Hering NA, Schulzke JD. Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig Dis. 2009;27:450–454.
- Ramakers JD, Mensink RP, Schaart G, et al. Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids. 2007;42:687–698.